Owens & Minor is focused on paying down debt and rethinking how it builds momentum in its “pure-play” Patient Direct business ...

Owens & Minor says it is in the final stages of selling its Products & Healthcare Services segment, says CEO Ed Pesicka.

Owens & Minor, Inc. faces financial distress with a 70% stock drop, weak margins, and strategic missteps. Click here to find out why OMI stock is a Hold.

Coliseum Capital, a ten-percent owner of Owens & Minor INC/VA/ (NYSE:OMI), has recently purchased shares of the company worth approximately $8.1 million. These purchases, executed between August 12 ...

Owens & Minor's canceled Rotech deal eases financial risks. Click to read a full investment analysis of OMI stock and why its ...

Citigroup analyst Daniel Grosslight maintained Owens & Minor with a Buy and lowered the price target from $11 to $7. Baird ...

Owens & Minor missed EPS estimates in Q2, but sales and EBITDA grew as it advanced plans to sell one of its segments.

Shares of Owens & Minor (NYSE:OMI) fell on Monday after the company's 2025 outlook failed to meet analysts' expectation, while also missing Q2 earnings estimates. The company said it expects its full ...

UBS analyst Kevin Caliendo lowered the firm’s price target on Owens & Minor to $7 from $13 and keeps a Buy rating on the shares. Owens & Minor’s ...

Owens & Minor Inc (OMI) reports a 3.3% revenue increase while focusing on strategic divestitures and overcoming supply chain ...

(OMI) on Monday reported a loss of $869.1 million in its second quarter. The Glen Allen, Virginia-based company said it had a ...

Medical supply and logistics company Owens & Minor (NYSE:OMI) will be announcing earnings results this Monday before market ...